DocDollars

Terumo Bct, Inc.

CO · United States · Reporting entity ID 100000010660

Total reported 2019–2025
$7.63M
#575 of 2,960 reporting companies — 0% of all reported industry payments
$1.39M in general payments across 1,531 records, plus $6.25M in research funding across 213 records.

How it breaks down

General payments $1,385,354
Research funding $6,248,411

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Terumo Bct, Inc. reported $7.63M to US doctors and teaching hospitals from 2019 to 2025, ranking #575 of 2,960 reporting companies. 82% of that was research funding and 18% general payments such as consulting, speaking, food and travel. 1,531 general payment records and 213 research records were filed.

Common questions about Terumo Bct, Inc.

How much has Terumo Bct, Inc. paid US doctors?

Terumo Bct, Inc. reported $7,633,764 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,385,354 in general payments, $6,248,411 in research funding.

How does Terumo Bct, Inc. rank among drug and device companies?

It ranks #575 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Terumo Bct, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.